Remove BioTech Remove Health Data Remove Life Science Remove Pharmaceuticals
article thumbnail

Emerging trends in the European HealthTech M&A market 2023

Lloyd Price

Growth of the life sciences sector: The life sciences sector is expected to continue to grow in 2023, driven by the development of new drugs and therapies, as well as the increasing demand for personalized medicine. The increased focus on digital health in the European HealthTech M&A market is a positive development.

article thumbnail

Americans’ Trust in U.S. Healthcare Lags Tech — and Women Are Particularly Cynical

Health Populi

I analyzed those general results with health/care implications here in Health Populi. In this study, the healthcare industry is comprised of five segments: hospitals and clinics; pharma; biotech (separate from pharma); consumer health (e.g., over-the-counter medicines); and, health insurance.

BioTech 205
article thumbnail

Medicine 2.0 : Implications of Connected Medical Devices & Digital Healthcare

Lloyd Price

Connected’ medical devices give patients greater control over their health data, and in turn enable doctors to use the data to prompt beneficial patient behaviour. Loetitia Jabri is regulatory, pharmaceutical & medical devices platforms associate director at ProductLife Group.